跳至主要内容
临床试验/NL-OMON55717
NL-OMON55717已完成不适用

Pulmonary artERial hypertenSion: bonE morPHOgeNEtic protein signaling out of control (PERSEPHONE) - PERSEPHONE

VU medisch centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Aim 1: BMP10 secretion by right atrial cardiomyocytes
  • Inclusion criteria patients:
  • - Patients with chronic thrombo-embolic pulmonary hypertension (CTEPH)
  • - Undergoing pulmonary endarterectomy, Inclusion criteria controls:
  • - Patients undergoing cardiac surgery and put on the heart-lung machine, Aim 2:
  • BMP10 release as a bio-assay of right heart failure, Inclusion criteria
  • - Idiopathic PAH (Invasively assessed mean pulmonary artery pressure >25 mmHg,
  • pulmonary artery wedge pressure <15 mmHg)
  • - Right heart catheterization and magnetic resonance imaging < 1 year before
  • participation
  • - Age > 18 years, Inclusion criteria controls:
  • - Age >18 years
  • - Age and sex-matched to patients
  • - We will include 10 subjects with a BMPR2 mutation without Pulmonary
  • Hypertension

排除标准

  • Aim 1: BMP10 secretion by right atrial cardiomyocytes, Exclusion criteria
  • - Age < 18 years, Exclusion criteria controls:
  • - Pulmonary hypertension (according to European Society of Cardiology
  • guidelines: echocardiography, tricuspid regurgitation peak velocity * 2.8
  • m/sec, estimated systolic pulmonary artery pressure * 36 mmHg and no additional
  • echocardiographic signs of pulmonary hypertension)(13)
  • - RV dysfunction (TAPSE < 16 mm)(13)
  • - RV (annulus) dilatation (RV end-diastolic diameter > 42 mm (base))(13)
  • - Tricuspid valve replacement or tricuspid annuloplasty
  • - Dilated right atrium or RA dysfunction (e.g. related to atrial fibrillation,
  • congenital abnormalities; cut-off values: area > 18 cm2)
  • - Age < 18 years, Aim 2: BMP10 release as a bio-assay of right heart failure,
  • Exclusion criteria patients:
  • - Pregnancy
  • - Claustrophobia
  • - Pacemaker, Exclusion criteria controls:
  • - Pulmonary hypertension (Invasively assessed mean pulmonary artery pressure >
  • - Increased pulmonary artery wedge pressure (>15 mmHg)
  • - Tricuspid valve dysfunction
  • - RV dysfunction
  • - Dilated right atrium or RA dysfunction (e.g. related to atrial fibrillation,
  • congenital abnormalities)
  • - Previous cardiac surgery
  • - Age < 18 years

研究者

发起方
VU medisch centrum

相似试验